Gastrointestinal effects and referred pain: The pronounced gastrointestinal side effects of GLP-1 therapyparticularly nausea, constipation, and abdominal distensioncan occasionally manifest as referred pain to the back
It has raised concern regarding the risk of blood clots
Whilst our Wegovy and Mounjaro weight-loss programmes are private and not currently used by the NHS, weve built the programmes focusing on scientific evidence, patient safety, and data security
Discontinuation and tolerability As with other incretin-based therapies, gastrointestinal side effects were common
You could think, "Oh, I'm just going to be really good for a couple weeks and I won't drink and I'll take off five pounds." No, no
The STEP trials, designed to evaluate semaglutide's efficacy for weight management, included participants aged 65 and older